Mereo Biopharma Group Plc Adr (MREO)

Sep 23, 2025

Atle Fund Management AB Has $2.07 Million Stock Position in Mereo BioPharma Group plcSponsored ADR $MREO - MarketBeat

Sep 23, 2025

Sep 17, 2025

Goldman Sachs Group Inc. Raises Stake in Mereo BioPharma Group plc – Sponsored ADR $MREO - Defense World

Sep 17, 2025

Sep 16, 2025

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), KalVista Pharmaceuticals (KALV) and Argenx Se (ARGX) - The Globe and Mail

Sep 16, 2025

Sep 12, 2025

Adage Capital Partners GP L.L.C. Has $3.83 Million Stock Position in Mereo BioPharma Group plcSponsored ADR $MREO - MarketBeat

Sep 12, 2025

Sep 11, 2025

Mereo BioPharma Group plcSponsored ADR (NASDAQ:MREO) Receives $7.40 Consensus PT from Brokerages - MarketBeat

Sep 11, 2025

Sep 07, 2025

Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Given Average Recommendation of “Buy” by Brokerages - Defense World

Sep 07, 2025

Sep 07, 2025

Frazier Life Sciences Management L.P. Increases Stock Holdings in Mereo BioPharma Group plcSponsored ADR $MREO - MarketBeat

Sep 07, 2025

Sep 03, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plcMREO - cnhinews.com

Sep 03, 2025

Sep 02, 2025

Upcoming Events - FinancialContent

Sep 02, 2025

Aug 29, 2025

Pomerantz LLP investigates Mereo BioPharma securities fraud claims. - AInvest

Aug 29, 2025

Aug 26, 2025

JPMorgan Chase & Co. Issues Positive Forecast for Mereo BioPharma Group (NASDAQ:MREO) Stock Price - Defense World

Aug 26, 2025

Aug 25, 2025

About Us - FinancialContent

Aug 25, 2025

Aug 17, 2025

Mereo BioPharma Group plc investigated for securities fraud and unlawful practices. - AInvest

Aug 17, 2025

Aug 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - GlobeNewswire Inc.

Aug 17, 2025

Aug 17, 2025

FY2026 EPS Estimates for MREO Lifted by Cantor Fitzgerald - Defense World

Aug 17, 2025

Aug 17, 2025

Analysts Set Mereo BioPharma Group plcSponsored ADR (NASDAQ:MREO) Price Target at $7.20 - MarketBeat

Aug 17, 2025

Aug 16, 2025

Leerink Partnrs Has Negative Outlook for MREO Q3 Earnings - Defense World

Aug 16, 2025

Aug 15, 2025

Analysts Offer Predictions for MREO Q3 Earnings - Defense World

Aug 15, 2025

Aug 13, 2025

Mereo BioPharma Group faces securities fraud investigation. - AInvest

Aug 13, 2025

Aug 13, 2025

Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Receives Average Rating of “Buy” from Analysts - Defense World

Aug 13, 2025

Aug 12, 2025

Mereo BioPharma ADR earnings beat, revenue fell short of estimates By Investing.com - Investing.com Nigeria

Aug 12, 2025

Aug 12, 2025

Mereo BioPharma Reports Q2 2025 Financial Results and Updates on Setrusumab Phase 3 Studies for Osteogenesis Imperfecta - Quiver Quantitative

Aug 12, 2025

Aug 12, 2025

Mereo's Setrusumab Phase 3 Trials Hit Key Safety Milestone: Year-End Results Coming for Rare Bone Disease - Stock Titan

Aug 12, 2025

Aug 12, 2025

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights - GlobeNewswire

Aug 12, 2025

Aug 11, 2025

Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Nektar Therapeutics (NKTR) - The Globe and Mail

Aug 11, 2025

Aug 11, 2025

Pomerantz LLP Investigates Mereo BioPharma Group Securities Fraud Claims. - AInvest

Aug 11, 2025

Aug 05, 2025

Pomerantz LLP investigates Mereo BioPharma Group securities fraud claims. - AInvest

Aug 05, 2025

Aug 01, 2025

Mereo BioPharma investigated for potential securities fraud. - AInvest

Aug 01, 2025

Aug 01, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - GlobeNewswire Inc.

Aug 01, 2025

Jul 31, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mereo BioPharma Group plc (MREO) And Encourages Shareholders to Connect - ACCESS Newswire

Jul 31, 2025

Jul 31, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plcMREO - MarketScreener

Jul 31, 2025

Jul 30, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Mereo BioPharma Group plc (MREO) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jul 30, 2025

Jul 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mereo BioPharma Group plc (MREO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jul 29, 2025

Jul 28, 2025

Mereo BioPharma Group plc (MREO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 28, 2025

Jul 27, 2025

Mereo BioPharma Group plc (MREO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 27, 2025

Jul 25, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mereo BioPharma Group plc (MREO) And Encourages Investors to Connect - ACCESS Newswire

Jul 25, 2025

Jul 24, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Mereo BioPharma Group plc (MREO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jul 24, 2025

Jul 23, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mereo BioPharma Group plc (MREO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jul 23, 2025

Jul 23, 2025

Investors in Mereo BioPharma Group plc (MREO) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire

Jul 23, 2025

Jul 23, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - GlobeNewswire Inc.

Jul 23, 2025

Jul 22, 2025

MREO ACTIVE INVESTIGATION: Lost Money on Mereo BioPharma Group plc? Contact Levi & Korsinsky Now - ACCESS Newswire

Jul 22, 2025